NYSE:BMY   Bristol-Myers Squibb Company
BMY looking to breakout from Jan 2020 run-up. Over all major EMAs. Active Sequence engaged on March 17, 2021 (8 over the 21). Additionally, looking at the Andrew Pitchfork it shows significant respect going back to 1994. Lastly, over the weekly POC from Volume Profile perspective and seems to be breaking out of the range. Initial price targets $70.12 and $77.88.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.